Ocugen Inc.  (OCGN)
Other Ticker:  
Price: $2.8800 $0.04 1.408%
Day's High: $2.89 Week Perf: 7.87 %
Day's Low: $ 2.78 30 Day Perf: 11.63 %
Volume (M): 3,345 52 Wk High: $ 17.65
Volume (M$): $ 9,632 52 Wk Avg: $4.66
Open: $2.80 52 Wk Low: $1.67

 Market Capitalization (Millions $) 622
 Shares Outstanding (Millions) 216
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -70
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 2

Ocugen Inc.

   Company Address: 11 Great Valley Parkway Malvern 19355 PA
   Company Phone Number: 328-4701   Stock Exchange / Ticker: NASDAQ OCGN
   OCGN is expected to report next financial results on November 08, 2022.


Stock Performances by Major Competitors

Year to Date Decrease / Increase
• View Complete Report

Frp Holdings Inc.

Strong Eps Underlines Double Digits Sales Growth at Frp Holdings Inc in the fiscal second quarter of 2022

For the fiscal second quarter of 2022 earnings per share soared by 600 % to $0.07 per share, followed by Sales increase of 13.34% to $9.63 millions, compared with the prior year period.

Riverview Bancorp Inc

Riverview Bancorp Inc declared most recent fiscal period operating income of $6.018 millions

Riverview Bancorp Inc reported soft results for the most recent fiscal period, where income fell by -19.23 % to $0.21 per share and Revenue decreased by -4.16% to $15.79 millions, year on year.

Resmed Inc.

Earnings and Sales Increased at Resmed Inc in the fourth quarter of 2022 earnings season

Resmed Inc had fourth quarter of 2022 earnings season Sales increase of 4.01% to $1.30 billions from $1.25 billions from the same quarter a year ago, company grew eps by 0.29 % to $1.32, from $1.32 in the prior year quarter.

Utg Inc.

Utg Inc disclosed second quarter of 2022 operating deficit of $-1.009337 millions

Utg Inc reported disappointing second quarter of 2022, where Sales melted down by -33.02% to $5.26 millions and company posted loss per share to $-0.24, compared to $0.57, in the same quarter a year ago.

Htg Molecular Diagnostics Inc

Demanding quarter for Htg Molecular Diagnostics Inc in the second quarter of 2022 earnings season

Weak demand caused increase in losses for the second quarter of 2022 earnings season, company's deficit per share grew to $-0.54 from $-0.39 where Sales fell by -28.09% to $1.49 millions from $2.07 millions a year ago.



Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

UONE's Profile

Stock Price

UONE's Financials

Business Description


Charts & Quotes

UONE's News


UONE's Competitors

Customers & Markets

Economic Indicators

UONE's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071